Friday, May 16, 2025
spot_img

Havila Kystruten AS: Trading Update for April 2025

Operational Highlights

  • Occupancy in April was 69%, up 4% compared to April 2024.
  • Average Cabin Revenue (ACR) increased by close to 30% year-over-year.
  • Total ticket revenue grew by over 20% year-over-year, despite reduced available capacity due to Havila Castor being in dry-dock.

Booking Position 2025

  • As of end-April, 60% of 2025 capacity is booked, representing about 80% of the full-year targeted cabin nights.
  • Occupancy for Q2 2025 is at 72% with 1.5 months remaining, compared to a final 69% in Q2 last year.
  • With booking distribution more balanced across north and south routes than last year allowing for further sales closer to departure, and Q4 campaigns starting about three months later, full year occupancy for 2025 is expected to trend higher moving forward.

Booking Position 2026

  • 21% of 2026 capacity is already booked at notably higher average prices (ACR) than 2025.
  • Forward bookings support continued revenue growth and EBITDA margin expansion into 2026.

*The KPIs provided are sourced from the Company’s (unaudited) booking system. Consequently, there may be variations or minor discrepancies in absolute figures and periodization compared to the reported financial statements. Revenue in currency (for ACR) is based on the booking system currency rate.

Contacts:
Chief Executive Officer: Bent Martini, +47 905 99 650
Chief Financial Officer: Aleksander Røynesdal, +47 413 18 114

 

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Powered by SlickText.com

Hot this week

AgEagle Aerial Systems Reports First Quarter Fiscal Year 2025 Financial Results

Improved financial performance highlighted by strong gross margin improvement...

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE)...

Novo Nordisk A/S: Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk

Bagsværd, Denmark, 16 May 2025 – Novo Nordisk today...

Topics

spot_img

Related Articles

Popular Categories

spot_img